日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML

结合 CRISPR-Cas9 和 TCR 交换技术,生成安全有效的脐带血来源 T 细胞产品,用于治疗儿童复发性急性髓系白血病

Vania Lo Presti ,Angelo Meringa ,Ester Dunnebach ,Alice van Velzen ,Aida Valera Moreira ,Ronald W Stam ,Rishi S Kotecha ,Anja Krippner-Heidenreich ,Olaf T Heidenreich ,Maud Plantinga ,Annelisa Cornel ,Zsolt Sebestyen ,Jurgen Kuball ,Niek P van Til # ,S Nierkens #

CRISPR screens decode cancer cell pathways that trigger γδ T cell detection

CRISPR筛选技术能够解码触发γδ T细胞检测的癌细胞通路。

Murad R Mamedov,Shane Vedova #,Jacob W Freimer #,Avinash Das Sahu,Amrita Ramesh,Maya M Arce,Angelo D Meringa,Mineto Ota,Peixin Amy Chen,Kristina Hanspers,Vinh Q Nguyen,Kirsten A Takeshima,Anne C Rios,Jonathan K Pritchard,Jürgen Kuball,Zsolt Sebestyen,Erin J Adams,Alexander Marson

γ9δ2 T-Cell Expansion and Phenotypic Profile Are Reflected in the CDR3δ Repertoire of Healthy Adults

健康成年人的 CDR3δ 库反映了 γ9δ2 T 细胞的扩增和表型特征

Anna Vyborova ,Anke Janssen ,Lucrezia Gatti ,Froso Karaiskaki ,Austin Yonika ,Sanne van Dooremalen ,Jasper Sanders ,Dennis X Beringer ,Trudy Straetemans ,Zsolt Sebestyen ,Jürgen Kuball

Adding Help to an HLA-A*24:02 Tumor-Reactive γδTCR Increases Tumor Control

为 HLA-A*24:02 肿瘤反应性 γδTCR 添加帮助可增强肿瘤控制

Inez Johanna, Patricia Hernández-López, Sabine Heijhuurs, Wouter Scheper, Laura Bongiovanni, Alain de Bruin, Dennis X Beringer, Rimke Oostvogels, Trudy Straetemans, Zsolt Sebestyen, Jürgen Kuball

γδ T-cell Receptors Derived from Breast Cancer-Infiltrating T Lymphocytes Mediate Antitumor Reactivity

源自乳腺癌浸润 T 淋巴细胞的 γδ T 细胞受体介导抗肿瘤反应

Anke Janssen #, Jose Villacorta Hidalgo #, Dennis X Beringer #, Sanne van Dooremalen, Febilla Fernando, Eline van Diest, Antonela R Terrizi, Peter Bronsert, Sylvia Kock, Annette Schmitt-Gräff, Martin Werner, Kerstin Heise, Marie Follo, Trudy Straetemans, Zsolt Sebestyen, Dmitry M Chudakov, Sofya A K

TEG011 persistence averts extramedullary tumor growth without exerting off-target toxicity against healthy tissues in a humanized HLA-A*24:02 transgenic mice

TEG011 持久性可避免髓外肿瘤生长,而不会对人源化 HLA-A*24:02 转基因小鼠的健康组织产生脱靶毒性

Inez Johanna, Patricia Hernández-López, Sabine Heijhuurs, Laura Bongiovanni, Alain de Bruin, Dennis Beringer, Sanne van Dooremalen, Leonard D Shultz, Fumihiko Ishikawa, Zsolt Sebestyen, Trudy Straetemans, Jürgen Kuball

Cellular immunotherapy on primary multiple myeloma expanded in a 3D bone marrow niche model

在 3D 骨髓微环境模型中扩展原发性多发性骨髓瘤的细胞免疫治疗

Maaike V J Braham, Monique C Minnema, Tineke Aarts, Zsolt Sebestyen, Trudy Straetemans, Anna Vyborova, Jurgen Kuball, F Cumhur Öner, Catherine Robin, Jacqueline Alblas

A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells

双特异性纳米抗体方法可发挥 Vγ9Vδ2-T 细胞强大且广泛适用的肿瘤细胞溶解能力

Renée C G de Bruin, John P Veluchamy, Sinéad M Lougheed, Famke L Schneiders, Silvia Lopez-Lastra, Roeland Lameris, Anita G Stam, Zsolt Sebestyen, Jürgen Kuball, Carla F M Molthoff, Erik Hooijberg, Rob C Roovers, James P Di Santo, Paul M P van Bergen En Henegouwen, Henk M W Verheul, Tanja D de Gruijl

Untouched GMP-Ready Purified Engineered Immune Cells to Treat Cancer

未经加工、符合 GMP 标准的纯化工程免疫细胞用于治疗癌症

Trudy Straetemans, Cordula Gründer, Sabine Heijhuurs, Samantha Hol, Ineke Slaper-Cortenbach, Halvard Bönig, Zsolt Sebestyen, Jürgen Kuball